OpenAI Misses Targets, Codex vs Claude, Elon-Altman Lawsuit, Retatrutide Goes Mainstream
Besties cover OpenAI Codex closing on Claude, AI cybersecurity as a breakout market, the Elon vs. Altman suit, big-tech capex explosion, an AI-vibecoding nightmare that wiped a codebase, and retatrutide peptides going mainstream. Chamath argues power & data centers are now AI's real chokepoint.
May 1, 2026
Health Signal